Intel slumps as potential foundry exit deepens investor gloom
Tan Lip-Bu said on Thursday he would further shrink Intel's workforce, halt work on two plants in Europe and slow another in Ohio, binning his ousted predecessor's strategy that relied on building costly facilities to restore its manufacturing edge.
The plan for such extreme measures follows a surprise second-quarter adjusted loss and a forecast for a bigger-than-expected loss in the third quarter.
The weakening financials pointed to more trouble for Intel after years of mismanagement eroded its PC and datacentre market share and left it with almost no presence in the AI market.
The disclosures 'revive long-unanswered questions on the chances of success for its foundry business and...what the path forward is if Intel does not develop leading edge manufacturing capability,' TD Cowen analyst Joshua Buchalter said.
'It's hard to understate the significance of this potential outcome in the context of the history of the semiconductor industry.'
BT in your inbox
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
Sign Up
Sign Up
As part of its new strategy, Intel may reserve the advanced 18A manufacturing process for its products and proceed with its next-generation 14A only if it lands a major external customer commits, Tan told analysts on the post-earnings call.
The move could put US$100 billion in assets at risk and deepen its dependence on rival TSMC, adding strain to margins already running at about half their historical highs.
'Intel Foundry is a big story and currently people are questioning how successful 18A is. A failure in 18A will be a broken story,' said Hendi Susanto, portfolio manager at Gabelli Funds.
Intel was set to lose nearly US$8 billion in market value, if current losses hold. Its current valuation of around US$100 billion is less than half of Advanced Micro Devices' more than US$260 billion.
The stock has lagged far behind rivals this year, rising 12.8 per cent compared with AI darling Nvidia's 30 per cent gain and AMD's 34 per cent. Intel trades at a 12-month forward price-to-earnings ratio of 42.55 versus 33.90 for Nvidia and 32.12 for AMD.
Since taking the helm in March, Tan has divested businesses, laid off employees and redirected resources as part of his strategic reset to revive the embattled chipmaker.
'There are no more blank checks,' he wrote in a memo to employees on Thursday. REUTERS
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
International Business Times
5 hours ago
- International Business Times
Vietnam Marks Medical Breakthrough With First Robotic Pediatric Brain Procedure
Robotic systems are fast becoming the new standard worldwide. According to Frontiers, the global medical robots market was valued at approximately US$27.7 billion in 2023, and is projected to hit US$127 billion by 2033, growing at a CAGR of 16.5%. Europe and North America remain leaders in adoption. In 2023, Europe alone had over 3,500 surgical robotic systems and performed more than 280,000 robotic surgeries, according to MarketGrowthReports. "Innovation like robot-assisted surgery isn't science fiction, it's the future of the health service," said UK Health Secretary Wes Streeting in The Scottish Sun. That future is no longer limited to the West. It has arrived in Southeast Asia, specifically, Vietnam. At Vinmec Central Park International Hospital (Ho Chi Minh City), surgeons performed the country's first pediatric stereo-electroencephalography (SEEG) using the AutoGuide™ robotic guidance system on a 9-year-old boy with drug-resistant epilepsy. The patient, B.Q.K. from Hanoi, had suffered from epilepsy since 2021. Despite undergoing multiple treatments in Vietnam and abroad, his seizures persisted. For five years, his family sought a solution that could restore their son's quality of life and allow for seizure-free sleep. That solution arrived in 2025. On June 17, 2025, a surgical team led by Dr. Truong Van Tri, with support from Japanese epilepsy expert Assoc. Prof. Dr. Shunsuke Nakae, performed a high-precision resection. The young patient after a life-changing breakthrough Handout Using AutoGuide, Vinmec doctors successfully implanted electrodes deep into the orbitofrontal cortex and inferior frontal gyrus—regions densely packed with neural networks and blood vessels. The robot worked in tandem with advanced imaging tools, including a 3.0 Tesla MRI and multi-channel EEG systems, to visualize the brain and track seizure activity. These technologies allowed the clinical team to identify the epileptogenic zone with high confidence, something that conventional surface EEG, PET, or MRI alone often fail to do in pediatric cases. "For the first time, we achieved near-perfect outcome in pediatric epilepsy surgery thanks to AutoGuide™. This is a critical milestone, especially for young patients who are highly vulnerable to major brain surgery," said Dr. Tri. The patient experienced no postoperative neurological deficits. Within a month, he returned to regular play, and his seizure frequency decreased by more than 95%, a life-changing turnaround. New Hope for Drug-Resistant Epilepsy Patients According to the World Health Organization, approximately 30% of epilepsy patients are drug-resistant, meaning they do not respond to medication. Surgery is often the most effective option for these patients, but it relies heavily on accurately localizing the epileptogenic zone. This process becomes even more difficult in children, where traditional tools like scalp EEG, MRI, and PET often yield inconclusive results. Robotic SEEG offers a minimally invasive and highly accurate alternative. Vinmec Central Park advances neurology through technology and international integration By combining robotic precision with multidisciplinary expertise, Vinmec Central Park is now among the few hospitals in Asia capable of performing pediatric SEEG with robotic assistance. Recognized as Vietnam's top private hospital system for expatriates and international patients (based on independent surveys), Vinmec is advancing the frontiers of neurology and precision medicine in Southeast Asia. This achievement reflects Vinmec's long-term strategy to develop centers of excellence through cutting-edge technology, personalized treatment, and global collaboration. As Vietnam continues to invest in AI, robotics, and precision healthcare, such milestones offer new possibilities for patients once deemed untreatable.
Business Times
7 hours ago
- Business Times
China state media asks Nvidia to prove H20 chips are secure
[HONG KONG] China state media is calling for Nvidia to prove that its H20 chip is secure, saying it cannot allow flawed chips into the country. China's top Internet watchdog summoned Nvidia representatives earlier this week to discuss what Chinese officials called significant security vulnerabilities in the H20. The Cyberspace Administration of China said that Nvidia would need to explain potential security risks and provide documents as needed, citing comments by US lawmakers about the need to install tracking capabilities on advanced chips being exported. 'As soon as 'backdoors' in chips are triggered, we can encounter a 'nightmare',' the People's Daily, a mouthpiece for the Chinese Communist Party, said in a commentary on Friday (Aug 1). 'We need to maintain the security of the cyberspace and we cannot allow 'infected' chips to be put to work.' More scrutiny of the artificial intelligence (AI) chip would throw a wrench China's already-contentious trade talks with the US. Santa Clara, California-based Nvidia had designed the H20 to comply with US export controls on its technology, and the company was hoping to start sales after the US granted a license. 'Cybersecurity is critically important to us,' Nvidia said on Thursday. 'Nvidia does not have 'backdoors' in our chips that would give anyone a remote way to access or control them.' US and Chinese officials met in Stockholm this week to discuss trade terms in talks that Chinese state media said that 'deepened mutual trust', though the two sides still have several disagreements over the potential new tariffs. The warning in People's Daily may signal that Chinese officials don't find H20s, which are less powerful than Nvidia's most high-end chips, to be worthy offerings. The Trump administration in April barred Nvidia from selling H20s to China in an escalation of the ongoing tech war between the world's two largest economies. Trump officials then pledged to lift those restrictions in July as part of a trade deal for China to allow more sales of rare-earth magnets needed to make a range of high-tech products. US Commerce Secretary Howard Lutnick had touted the resumption of sales of the H20 as a breakthrough that came from bilateral discussions in London, framing it as a concession to China. US Treasury Secretary Scott Bessent, meanwhile, said earlier this week that the magnet issue has been 'solved'. However, it is unclear whether Nvidia has received licenses to resume shipping those semiconductors. Nvidia boss Jensen Huang himself recently concluded a high-profile visit to Beijing, where he feted national Chinese champions such as DeepSeek and celebrated the country's rising prowess in AI. The billionaire had denied Nvidia installed backdoors in its product, saying that would not make business sense. BLOOMBERG
Business Times
7 hours ago
- Business Times
Brunei tweaks Bridgewater bet to a lucrative 20% stake in firm
[NEW YORK] Brunei's sovereign wealth fund pulled money from an investment in a Bridgewater Associates strategy to buy an almost 20% stake in the hedge fund manager's holding company, a move that has helped spur higher gains for other institutional investors. The Brunei Investment Agency is the latest longstanding client to buy a piece of the firm founded by Ray Dalio, which managed US$92 billion as at Dec 31. It's unclear which Bridgewater vehicle Brunei pulled money from, although the sovereign wealth fund remains an investor in all of the firm's funds, according to a source familiar with the money manager. Bridgewater's flagship Pure Alpha II, like many macro funds, has improved its performance in the past few years, but over a longer period, returns have been uneven. That means a long-term investment in the firm itself can be more lucrative than betting on its most popular product. Bridgewater has been selling stakes to institutions for more than a decade. The Teacher Retirement System of Texas, the Ontario Municipal Employees Retirement System, Singapore's sovereign wealth fund and the International Monetary Fund have all purchased a piece of the Westport, Connecticut-based firm. The Texas teachers pension fund invested US$250 million in Bridgewater's holding company in 2012 and reported making an annualised return of 8.7 per cent to Mar 31. An investor in Pure Alpha would have gained an annualised 2 per cent from the beginning of 2012 to June 2025. Last year, the fund climbed 11.3 per cent and it's up 17 per cent in the first half of this year. Dalio recently completed his exit from the company, selling the final slug of his remaining shares in the money manager he started 50 years ago, and resigning from the board. BLOOMBERG
